Copyright Reports & Markets. All rights reserved.

Global and China Hereditary Cancer Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 RNA Testing
    • 1.2.3 DNA Testing
  • 1.3 Market by Application
    • 1.3.1 Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Breast Cancer
    • 1.3.3 Gastrointestinal Cancer
    • 1.3.4 Prostate Cancer
    • 1.3.5 Respiratory/Lung Cancer
    • 1.3.6 Other Cancers
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Hereditary Cancer Testing Market Perspective (2015-2026)
  • 2.2 Global Hereditary Cancer Testing Growth Trends by Regions
    • 2.2.1 Hereditary Cancer Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Hereditary Cancer Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Hereditary Cancer Testing Players by Market Size
    • 3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
  • 3.4 Global Hereditary Cancer Testing Market Concentration Ratio
    • 3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2019
  • 3.5 Key Players Hereditary Cancer Testing Area Served
  • 3.6 Key Players Hereditary Cancer Testing Product Solution and Service
  • 3.7 Date of Enter into Hereditary Cancer Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Hereditary Cancer Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2021-2026)

5 Hereditary Cancer Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Hereditary Cancer Testing Market Size (2015-2026)
  • 6.2 North America Hereditary Cancer Testing Market Size by Type (2015-2020)
  • 6.3 North America Hereditary Cancer Testing Market Size by Application (2015-2020)
  • 6.4 North America Hereditary Cancer Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Hereditary Cancer Testing Market Size (2015-2026)
  • 7.2 Europe Hereditary Cancer Testing Market Size by Type (2015-2020)
  • 7.3 Europe Hereditary Cancer Testing Market Size by Application (2015-2020)
  • 7.4 Europe Hereditary Cancer Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Hereditary Cancer Testing Market Size (2015-2026)
  • 8.2 China Hereditary Cancer Testing Market Size by Type (2015-2020)
  • 8.3 China Hereditary Cancer Testing Market Size by Application (2015-2020)
  • 8.4 China Hereditary Cancer Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Hereditary Cancer Testing Market Size (2015-2026)
  • 9.2 Japan Hereditary Cancer Testing Market Size by Type (2015-2020)
  • 9.3 Japan Hereditary Cancer Testing Market Size by Application (2015-2020)
  • 9.4 Japan Hereditary Cancer Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Hereditary Cancer Testing Market Size (2015-2026)
  • 10.2 Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Hereditary Cancer Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Ambry Genetics (Konica Minota)
    • 11.1.1 Ambry Genetics (Konica Minota) Company Details
    • 11.1.2 Ambry Genetics (Konica Minota) Business Overview
    • 11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
    • 11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020))
    • 11.1.5 Ambry Genetics (Konica Minota) Recent Development
  • 11.2 Asper Biogene
    • 11.2.1 Asper Biogene Company Details
    • 11.2.2 Asper Biogene Business Overview
    • 11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
    • 11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.2.5 Asper Biogene Recent Development
  • 11.3 Natera
    • 11.3.1 Natera Company Details
    • 11.3.2 Natera Business Overview
    • 11.3.3 Natera Hereditary Cancer Testing Introduction
    • 11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.3.5 Natera Recent Development
  • 11.4 Caris Life Sciences
    • 11.4.1 Caris Life Sciences Company Details
    • 11.4.2 Caris Life Sciences Business Overview
    • 11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
    • 11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.4.5 Caris Life Sciences Recent Development
  • 11.5 BioReference Laboratories (GeneDx)
    • 11.5.1 BioReference Laboratories (GeneDx) Company Details
    • 11.5.2 BioReference Laboratories (GeneDx) Business Overview
    • 11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
    • 11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.5.5 BioReference Laboratories (GeneDx) Recent Development
  • 11.6 LabSolutions
    • 11.6.1 LabSolutions Company Details
    • 11.6.2 LabSolutions Business Overview
    • 11.6.3 LabSolutions Hereditary Cancer Testing Introduction
    • 11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.6.5 LabSolutions Recent Development
  • 11.7 Progenity，Inc
    • 11.7.1 Progenity，Inc Company Details
    • 11.7.2 Progenity，Inc Business Overview
    • 11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
    • 11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.7.5 Progenity，Inc Recent Development
  • 11.8 ARUP Laboratories
    • 11.8.1 ARUP Laboratories Company Details
    • 11.8.2 ARUP Laboratories Business Overview
    • 11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
    • 11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.8.5 ARUP Laboratories Recent Development
  • 11.9 NeoGenomics
    • 11.9.1 NeoGenomics Company Details
    • 11.9.2 NeoGenomics Business Overview
    • 11.9.3 NeoGenomics Hereditary Cancer Testing Introduction
    • 11.9.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.9.5 NeoGenomics Recent Development
  • 11.10 Blueprint Genetics
    • 11.10.1 Blueprint Genetics Company Details
    • 11.10.2 Blueprint Genetics Business Overview
    • 11.10.3 Blueprint Genetics Hereditary Cancer Testing Introduction
    • 11.10.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 11.10.5 Blueprint Genetics Recent Development
  • 11.11 CellMax Life
    • 10.11.1 CellMax Life Company Details
    • 10.11.2 CellMax Life Business Overview
    • 10.11.3 CellMax Life Hereditary Cancer Testing Introduction
    • 10.11.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 10.11.5 CellMax Life Recent Development
  • 11.12 Fulgent Genetics
    • 10.12.1 Fulgent Genetics Company Details
    • 10.12.2 Fulgent Genetics Business Overview
    • 10.12.3 Fulgent Genetics Hereditary Cancer Testing Introduction
    • 10.12.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 10.12.5 Fulgent Genetics Recent Development
  • 11.13 Myriad Genetics
    • 10.13.1 Myriad Genetics Company Details
    • 10.13.2 Myriad Genetics Business Overview
    • 10.13.3 Myriad Genetics Hereditary Cancer Testing Introduction
    • 10.13.4 Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 10.13.5 Myriad Genetics Recent Development
  • 11.14 Myogenes
    • 10.14.1 Myogenes Company Details
    • 10.14.2 Myogenes Business Overview
    • 10.14.3 Myogenes Hereditary Cancer Testing Introduction
    • 10.14.4 Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 10.14.5 Myogenes Recent Development
  • 11.15 LabCorp
    • 10.15.1 LabCorp Company Details
    • 10.15.2 LabCorp Business Overview
    • 10.15.3 LabCorp Hereditary Cancer Testing Introduction
    • 10.15.4 LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 10.15.5 LabCorp Recent Development
  • 11.16 Quest Diagnostics
    • 10.16.1 Quest Diagnostics Company Details
    • 10.16.2 Quest Diagnostics Business Overview
    • 10.16.3 Quest Diagnostics Hereditary Cancer Testing Introduction
    • 10.16.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 10.16.5 Quest Diagnostics Recent Development
  • 11.17 Pathway Genomics
    • 10.17.1 Pathway Genomics Company Details
    • 10.17.2 Pathway Genomics Business Overview
    • 10.17.3 Pathway Genomics Hereditary Cancer Testing Introduction
    • 10.17.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 10.17.5 Pathway Genomics Recent Development
  • 11.18 Strand Life Sciences
    • 10.18.1 Strand Life Sciences Company Details
    • 10.18.2 Strand Life Sciences Business Overview
    • 10.18.3 Strand Life Sciences Hereditary Cancer Testing Introduction
    • 10.18.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
    • 10.18.5 Strand Life Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Hereditary Cancer Testing Scope and Market Size
    Hereditary Cancer Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    RNA Testing
    DNA Testing

    Market segment by Application, split into
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Other Cancers

    Based on regional and country-level analysis, the Hereditary Cancer Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Hereditary Cancer Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Ambry Genetics (Konica Minota)
    Asper Biogene
    Natera
    Caris Life Sciences
    BioReference Laboratories (GeneDx)
    LabSolutions
    Progenity，Inc
    ARUP Laboratories
    NeoGenomics
    Blueprint Genetics
    CellMax Life
    Fulgent Genetics
    Myriad Genetics
    Myogenes
    LabCorp
    Quest Diagnostics
    Pathway Genomics
    Strand Life Sciences

    Buy now